GSK-1070806 | Interleukin Related interleukin-related.com

Product Name :
GSK-1070806

Search keywords :
GSK-1070806

drugId :
null

Target Vo:
Interleukin 18

Target Vo Short Name :
IL18

Moa_Name:
Interleukin 18 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Glaxosmithkline (China) Investment Co Ltd

Active Indication_Name:
Dermatitis, Atopic

In Active Indication_Name:
Rejection of renal transplantation

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Occludin Antibody Epigenetic Reader Domain
Phospho-Src(Y419) Rabbit mAb Technical Information
Cyclin D3 Antibody: Cyclin D3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 33 kDa, targeting to Cyclin D3. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts